Citation:Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M 1992

From Cancer Guidelines Wiki

Citation


Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992 Sep;33(9):1155-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/1427364.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the incidence of neoplasia in patients with BO?Associate Professor Freddy Sitascompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?David Whitemancompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the incidence of neoplasia in patients with BO?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the incidence of neoplasia in patients with BO?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Are there groups of patients with non-dysplastic BO that require more frequent surveillance?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Are there groups of patients with non-dysplastic BO that require more frequent surveillance?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Are there groups of patients with BO that can be discharged from surveillance?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Are there groups of patients with BO that can be discharged from surveillance?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by